Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- REDNVIA Co., Ltd.
- Target Recruit Count
- 580
- Registration Number
- NCT05143177
- Locations
- 🇺🇸
Mayo Clinic, AZ, Phoenix, Arizona, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
News
No news found